Promising lymphoma therapy trial halted after just one patient

NCT ID NCT05994157

First seen Mar 28, 2026 · Last updated Apr 29, 2026 · Updated 2 times

Summary

This early-phase trial tested a two-step radiation treatment for people with non-Hodgkin lymphoma that had come back or stopped responding to standard therapies. Only one person took part before the study was stopped. The goal was to find a safe dose and see if the treatment could help control the disease.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON-HODGKIN LYMPHOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • City of Hope

    Duarte, California, 91010, United States

  • Corewell Health-BAMF Health

    Grand Rapids, Michigan, 49503, United States

  • East Carolina University Leo W. Jenkins Cancer Center

    Greenville, North Carolina, 27834, United States

  • HonorHealth

    Scottsdale, Arizona, 85258, United States

  • Memorial Sloan Kettering Cancer Center

    New York, New York, 10065, United States

  • Stony Brook Cancer Center

    Stony Brook, New York, 11794, United States

Conditions

Explore the condition pages connected to this study.